PureTech Health plc (LON:PRTC)
London · Delayed Price · Currency is GBP · Price in GBX 127.67
+2.07 (1.65%)
Mar 5, 2026, 10:14 AM GMT
PureTech Health Market Cap
PureTech Health has a market cap or net worth of 303.71 million as of March 5, 2026. Its market cap has decreased by -13.11% in one year.
Market Cap
303.71M
Enterprise Value
176.23M
Revenue
4.66M
Ranking
n/a
PE Ratio
8.54
Stock Price
127.67
Market Cap Chart
Since June 19, 2015, PureTech Health's market cap has decreased from 404.50M to 303.71M, a decrease of -24.92%. That is a compound annual growth rate of -2.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 303.71M | 0.53% |
| Dec 31, 2025 | 302.11M | -15.99% |
| Dec 31, 2024 | 359.61M | -31.88% |
| Dec 29, 2023 | 527.94M | -28.89% |
| Dec 30, 2022 | 742.38M | -11.66% |
| Dec 31, 2021 | 840.37M | -26.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 1.83B |
| Oxford Nanopore Technologies | 1.09B |
| Oxford Biomedica | 756.67M |
| Avacta Group | 299.62M |
| Scancell Holdings | 128.68M |
| 4basebio | 83.58M |
| Bioventix | 75.76M |
| Hemogenyx Pharmaceuticals | 62.33M |